[Elsevier] Transcriptomic stratification predicts response to rituximab, abatacept, or the association of hydroxychloroquine and leflunomide in 3 randomised controlled clinical trials of Sjgren’s disease

pharma.clinical Post time Half hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-09-21 22:40
Reward10points

journal:Annals of the Rheumatic Diseases

Authors:Baptiste Chevet; Valérie Devauchelle-Pensec; Elena Pontarini; Valentin Baloche; Michele Bombardieri; Simon J. Bowman; Michael Barnes; Antoine G. Sreih; Jinqi Liu; Sheila Kelly; Antonia Christodoulou; Philippe Moingeon; Laurence Laigle; Perrine Soret; Christelle Le Dantec; Jacques-Olivier Pers; Marta E. Alarcon-Riquelme; Guillermo Barturen; Xavier Mariette; Joel van Roon; Raphaèle Seror; Gaetane Nocturne; Divi Cornec; Nathan Foulquier

Published date:2026-5-

DOI:10.1016/j.ard.2025.11.017

PDF link:https://www.sciencedirect.com/sc ... 003496725045492/pdf

Article link:https://doi.org/10.1016/j.ard.2025.11.017

Article Source:Elsevier BV


Remark:
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Senior Member
  • post

  • reply

  • points

    2345

Return to the list